Elekta, Inc. recalls MOSAIQ Oncology Information System
- Recall date
- August 3, 2018
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-2917-2018
- FDA classification
- Class II
- Brand / firm
- Elekta, Inc.
- Sold / distributed
- AK, AZ, CA, CO, CT, DC, FL, GA, IA, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NC, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, SD, TN, TX, WA, WI, WV, and WY Australia, Canada, Ireland, New Zealand, Portugal, Singapore, South Africa, Spain, Sweden, and United Kingdom
Why it was recalled
Order Status Remains Approved When Should Indicate Complete.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
MOSAIQ Oncology Information System
Get recall alerts
Free email alert whenever Elekta, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Elekta, Inc.